Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Mar;17(3):108-13.
doi: 10.1016/0165-6147(96)10002-x.

Adenosine receptor ligands: differences with acute versus chronic treatment

Affiliations
Review

Adenosine receptor ligands: differences with acute versus chronic treatment

K A Jacobson et al. Trends Pharmacol Sci. 1996 Mar.

Abstract

Adenosine receptors have been the target of intense research with respect to potential use of selective ligands in a variety of therapeutic areas. Caffeine and theophylline are adenosine receptor antagonists, and over the past three decades a wide range of selective agonists and antagonists for adenosine receptor subtypes have been developed. A complication to the therapeutic use of adenosine receptor ligands is the observation that the effects of acute administration of a particular ligand can be diametrically opposite to the chronic effects of the same ligand. This 'effect inversion' is discussed here by Ken Jacobson and colleagues, and has been observed for effects on cognitive processes, seizures and ischaemic damage.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of a: agonists. and b: antagonists at adenosine receptors APEC, 2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5′-N-ethylcarboxamidoadenosine; CPT, 8-cyclopentyltheophylline; CPX. 8-cyclopentyl-1,3-dipropylxanthine; CSC, 8-(3-chlorostyryl)caffeine; DPMA, N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine: IB-MECA, N6-(3-iodobenzyl)-5′-N-methylcarboxamidoadenosine; and XAC. 8-(4-[({[(2-aminoethyl)amino]carbonyl}methyl)oxy]phenyl}-1,3-dipropylxanthine.
Fig. 2
Fig. 2
Effect of chronic administration of caffeine on the densities of several receptors and an ion channel in various brain regions. (■, cortex; □, cerebellum; and ■, striatum.) Caffeine was ingested in drinking water (1 g l−1) for 4 days by male NIH Swiss mice. Binding assays were carried out four hours after cessation of caffeine administration via the drinking water. Values are calculated from data in Refs , , and expressed as percent of control levels. *p<0.05 significantly different from control values.

References

    1. Nehlig A, Daval J-L, Debry G. Brain Res. Rev. 1992;17:139–169. - PubMed
    1. Fredholm BB. Pharmacol Toxicol. 1995;76:93–101. - PubMed
    1. Daly JW. In: Caffeine, Coffee and Health. Garattini S, editor. Raven Press; 1993. pp. 97–150.
    1. Johansson B, et al. Naunyn-Schmied. Arch. Pharmacol. 1993;347:407–414. - PubMed
    1. Daly JW, Shi D, Nikodijević O, Jacobson KA. Pharmacopsychoecologia. 1994;7:201–213. - PMC - PubMed